Everolimus-induced Pneumonitis after Drug-eluting Stent Implantation: A Case Report

Journal Article · Thu Aug 01 00:00:00 EDT 2013 · Cardiovascular and Interventional Radiology

DOI:https://doi.org/10.1007/S00270-012-0477-Y· OSTI ID:22121753

Sakamoto, Susumu; Kikuchi, Naoshi; Ichikawa, Atsuo; Sano, Go; Satoh, Keita; Sugino, Keishi; Isobe, Kazutoshi; Takai, Yujiro ^[1]; Shibuya, Kazutoshi ^[2]; Homma, Sakae ^[1]

---

1. Toho University School of Medicine, Department of Respiratory Medicine (Japan)
2. Toho University School of Medicine, Department of Pathology (Japan)

Despite the wide use of everolimus as an antineoplastic coating agent for coronary stents to reduce the rate of restenosis, little is known about the health hazards of everolimus-eluting stents (EES). We describe a case of pneumonitis that developed 2 months after EES implantation for angina. Lung pathology demonstrated an organizing pneumonia pattern that responded to corticosteroid therapy. Although the efficacy of EES for ischemic heart disease is well established, EES carries a risk of pneumonitis.

• OSTI ID: 22121753
• Journal Information: Cardiovascular and Interventional Radiology, Vol. 36, Issue 4; Other Information: Copyright (c) 2013 Springer Science+Business Media New York and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE); Article Copyright (c) 2012 Springer Science+Business Media, LLC and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE); Country of input: International Atomic Energy Agency (IAEA); ISSN 0174-1551
• Country of Publication: United States
• Language: English

Related Subjects

62 RADIOLOGY AND NUCLEAR MEDICINE
CORONARIES
CORTICOSTEROIDS
DRUGS
HEALTH HAZARDS
ISCHEMIA
LUNGS
NEOPLASMS
PATHOLOGY
PNEUMONIA
PNEUMONITIS
RADIOLOGY
THERAPY